William J. McBride
Neuroscience · Indiana University
Neurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and SignalingRadiopharmaceutical Chemistry and ApplicationsMonoclonal and Polyclonal Antibodies Research
Publications
670
Citations
27,716
Est. group size
—
Recurring co-author estimate
Active years
65
Publishing since 1962
Publication cadence
Publications per year over the last 10 years — averaging 9.2/year recently
Recent publications
- Glutamate transmission in the prelimbic cortex and nucleus accumbens shell is involved in ethanol reinforcement and drinking in rats
Frontiers in Behavioral Neuroscience · 2026
- N11 Switching from intravenous to subcutaneous infliximab enhances trough levels and can facilitate de-escalation of concomitant immunomodulation, irrespective of the HLA DQA1*05 status: a prospective real-world study
Journal of Crohn s and Colitis · 2025
- N12 Patient perspectives of switch in route of administration among patients established on long term intravenous Infliximab therapy
Journal of Crohn s and Colitis · 2025
- Inhibitory and excitatory conditioned cues associated with alcohol differentially modulate the nucleus accumbens shell: involvement of 5-HT7 receptors
Frontiers in Psychiatry · 2025
- P309 Impact of EBV Status on decision making for advanced therapies in IBD Patients
Journal of Crohn s and Colitis · 2024
- Data from A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma
2023
- Inhibitory and excitatory alcohol-seeking cues distinct roles in behavior, neurochemistry, and mesolimbic pathway in alcohol preferring (P) rats
Drug and Alcohol Dependence · 2023
- Supplementary Figure 1 from A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma
2023
- Data from Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non–Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody
2023
- Data from A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma
2023
- Supplementary Figure 1 from A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma
2023
- Supplementary Figure 2 from A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma
2023
- Supplementary Figure 2 from A Novel Bispecific, Trivalent Antibody Construct for Targeting Pancreatic Carcinoma
2023
- Supplementary Materials and Methods from Improved Therapeutic Results by Pretargeted Radioimmunotherapy of Non–Hodgkin's Lymphoma with a New Recombinant, Trivalent, Anti-CD20, Bispecific Antibody
2023
- Supplementary Figure Legend from CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer
2023
Publishes in
- PMC×6
- Alcoholism Clinical and Experimental Research×5
- PLoS neglected tropical diseases×4
- PLoS ONE×3
- Psychopharmacology×3
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 9, 2026.
Claim or correct this profile